These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 7861345)

  • 1. Fulminant pseudomembranous colitis (PMC) following triple therapy for Helicobacter pylori.
    Awad RW; Ward KL; Hawker PC
    J R Coll Surg Edinb; 1994 Oct; 39(5):319. PubMed ID: 7861345
    [No Abstract]   [Full Text] [Related]  

  • 2. Triple therapy vs. amoxicillin plus omeprazole for treatment of Helicobacter pylori infection: a multicenter, prospective, randomized, controlled study of efficacy and side effects.
    Thijs JC; van Zwet AA; Moolenaar W; Wolfhagen MJ; ten Bokkel Huinink J
    Am J Gastroenterol; 1996 Jan; 91(1):93-7. PubMed ID: 8561152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly effective twice-daily triple therapies for Helicobacter pylori infection and peptic ulcer disease: does in vitro metronidazole resistance have any clinical relevance?
    Lerang F; Moum B; Haug JB; Tolås P; Breder O; Aubert E; Høie O; Søberg T; Flaaten B; Farup P; Berge T
    Am J Gastroenterol; 1997 Feb; 92(2):248-53. PubMed ID: 9040200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clostridium difficile colitis associated with treatment of Helicobacter pylori infection.
    Nawaz A; Mohammed I; Ahsan K; Karakurum A; Hadjiyane C; Pellecchia C
    Am J Gastroenterol; 1998 Jul; 93(7):1175-6. PubMed ID: 9672359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized comparison of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori.
    Laine L; Estrada R; Trujillo M; Emami S
    Am J Gastroenterol; 1997 Dec; 92(12):2213-5. PubMed ID: 9399755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One-week ranitidine bismuth citrate versus colloidal bismuth subcitrate-based anti-Helicobacter triple therapy: a prospective randomized controlled trial.
    Kung NN; Sung JJ; Yuen NW; Li TH; Ng PW; Lai WM; Lui YH; Lam KN; Choi CH; Leung EM
    Am J Gastroenterol; 1999 Mar; 94(3):721-4. PubMed ID: 10086657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effectiveness of triple therapy to eradicate H. pylori in patients after failed therapy with omeprazole/amoxicillin].
    Zala G; Schwery S; Giezendanner S; Flury R; Wüst J; Meyenberger C; Wirth HP
    Schweiz Med Wochenschr; 1996 Feb; 126(5):153-8. PubMed ID: 8685685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A four-year follow-up of duodenal ulcer patients after Helicobacter pylori eradication.
    Tepes B; Kavcic B; Gubina M; Krizman I
    Hepatogastroenterology; 1999; 46(27):1746-50. PubMed ID: 10430336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of high efficacy, lower dose triple therapy to reduce side effects of eradicating Helicobacter pylori.
    Borody TJ; Brandl S; Andrews P; Ferch N; Jankiewicz E; Hyland L
    Am J Gastroenterol; 1994 Jan; 89(1):33-8. PubMed ID: 8273794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison between omeprazole-based triple therapy and bismuth-based triple therapy for the treatment of Helicobacter pylori infection: a prospective randomized 1-yr follow-up study.
    Lerang F; Moum B; Ragnhildstveit E; Haug JB; Hauge T; Tolås P; Aubert E; Henriksen M; Efskind PS; Nicolaysen K; Søberg T; Odegaard A; Berge T
    Am J Gastroenterol; 1997 Apr; 92(4):653-8. PubMed ID: 9128317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two-day quadruple therapy for cure of Helicobacter pylori infection: a comparative, randomized trial.
    Calvet X; García N; Campo R; Brullet E; Comet R; Navarro M
    Am J Gastroenterol; 1998 Jun; 93(6):932-4. PubMed ID: 9647022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nifuratel-containing initial anti-Helicobacter pylori triple therapy in children.
    Nijevitch AA; Sataev VU; Akhmadeyeva EN; Arsamastsev AG
    Helicobacter; 2007 Apr; 12(2):132-5. PubMed ID: 17309749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel bismuth-metronidazole-tetracycline triple-layer tablet for treatment of Helicobacter pylori.
    Graham DY; Opekun AR; Belson G; El-Zimaity HM; Carlson MR
    Aliment Pharmacol Ther; 2005 Jan; 21(2):165-8. PubMed ID: 15679766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omeprazole 40 mg o.m. combined with amoxycillin alone or with amoxycillin and metronidazole in the eradication of Helicobacter pylori.
    Goh KL; Peh SC; Parasakthi N; Wong NW; Tan KK; Lo YL
    Am J Gastroenterol; 1994 Oct; 89(10):1789-92. PubMed ID: 7942668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Helicobacter pylori eradication in childhood after failure of initial treatment: advantage of quadruple therapy with nifuratel to furazolidone.
    Nijevitch AA; Shcherbakov PL; Sataev VU; Khasanov RSh; Al Khashash R; Tuygunov MM
    Aliment Pharmacol Ther; 2005 Nov; 22(9):881-7. PubMed ID: 16225499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lansoprazole, levofloxacin and amoxicillin triple therapy vs. quadruple therapy as second-line treatment of resistant Helicobacter pylori infection.
    Wong WM; Gu Q; Chu KM; Yee YK; Fung FM; Tong TS; Chan AO; Lai KC; Chan CK; Wong BC
    Aliment Pharmacol Ther; 2006 Feb; 23(3):421-7. PubMed ID: 16423001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Helicobacter pylori infection and peptic ulcer].
    Jaspersen D; Hammar CH
    Dtsch Med Wochenschr; 1993 Dec; 118(48):1783. PubMed ID: 8253034
    [No Abstract]   [Full Text] [Related]  

  • 18. Primary and acquired Helicobacter pylori resistance to clarithromycin, metronidazole, and amoxicillin--influence on treatment outcome.
    Adamek RJ; Suerbaum S; Pfaffenbach B; Opferkuch W
    Am J Gastroenterol; 1998 Mar; 93(3):386-9. PubMed ID: 9517645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Helicobacter pylori eradication therapy success regarding different treatment period based on clarithromycin or metronidazole triple-therapy regimens.
    Filipec Kanizaj T; Katicic M; Skurla B; Ticak M; Plecko V; Kalenic S
    Helicobacter; 2009 Feb; 14(1):29-35. PubMed ID: 19191893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of metronidazole as second-line drug for the treatment of Helicobacter pylori Infection in the Japanese population: a multicenter study in the Tokyo Metropolitan Area.
    Matsuhisa T; Kawai T; Masaoka T; Suzuki H; Ito M; Kawamura Y; Tokunaga K; Suzuki M; Mine T; Takahashi S; Sakaki N
    Helicobacter; 2006 Jun; 11(3):152-8. PubMed ID: 16684262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.